Notably, INTS13, which is significantly up-regulated in rectum adenocarcinoma, lung cancer small cells, and cholangiocarcinoma, is the most frequently deregulated INT gene at the transcriptional level (eight out of 22 analyzed cancer types). The gene discussed is INTS13; the disease is rectum adenocarcinoma.